Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells

<p>Abstract</p> <p>Background</p> <p>Hepatocellular carcinoma (HCC) is an aggressive cancer, and is the third leading cause of cancer death worldwide. Standard therapy is ineffective partly because HCC is intrinsically resistant to conventional chemotherapy. Its poor pr...

Full description

Bibliographic Details
Main Authors: Grepper Susan, Chua Mei-Sze, Wei Wei, So Samuel K
Format: Article
Language:English
Published: BMC 2009-09-01
Series:Molecular Cancer
Online Access:http://www.molecular-cancer.com/content/8/1/76
id doaj-309e7e3a6add45fdacfce634569d7ee3
record_format Article
spelling doaj-309e7e3a6add45fdacfce634569d7ee32020-11-25T00:57:16ZengBMCMolecular Cancer1476-45982009-09-01817610.1186/1476-4598-8-76Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cellsGrepper SusanChua Mei-SzeWei WeiSo Samuel K<p>Abstract</p> <p>Background</p> <p>Hepatocellular carcinoma (HCC) is an aggressive cancer, and is the third leading cause of cancer death worldwide. Standard therapy is ineffective partly because HCC is intrinsically resistant to conventional chemotherapy. Its poor prognosis and limited treatment options make it critical to develop novel and selective chemotherapeutic agents. Since the Wnt/β-catenin pathway is essential in HCC carcinogenesis, we studied the inhibition of Wnt-1-mediated signaling as a potential molecular target in HCC.</p> <p>Results</p> <p>We demonstrated that Wnt-1 is highly expressed in human hepatoma cell lines and a subgroup of human HCC tissues compared to paired adjacent non-tumor tissues. An anti-Wnt-1 antibody dose-dependently decreased viability and proliferation of Huh7 and Hep40 cells over-expressing Wnt-1 and harboring wild type β-catenin, but did not affect normal hepatocytes with undetectable Wnt-1 expression. Apoptosis was also observed in Huh7 and Hep40 cells after treatment with anti-Wnt-1 antibody. In these two cell lines, the anti-Wnt-1 antibody decreased β-catenin/Tcf4 transcriptional activities, which were associated with down-regulation of the endogenous β-catenin/Tcf4 target genes c-Myc, cyclin D1, and survivin. Intratumoral injection of anti-Wnt-1 antibody suppressed <it>in vivo </it>tumor growth in a Huh7 xenograft model, which was also associated with apoptosis and reduced c-Myc, cyclin D1, and survivin expressions.</p> <p>Conclusion</p> <p>Our results suggest that Wnt-1 is a survival factor for HCC cells, and that the blockade of Wnt-1-mediated signaling may offer a potential pathway-specific therapeutic strategy for the treatment of a subgroup of HCC that over-expresses Wnt-1.</p> http://www.molecular-cancer.com/content/8/1/76
collection DOAJ
language English
format Article
sources DOAJ
author Grepper Susan
Chua Mei-Sze
Wei Wei
So Samuel K
spellingShingle Grepper Susan
Chua Mei-Sze
Wei Wei
So Samuel K
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
Molecular Cancer
author_facet Grepper Susan
Chua Mei-Sze
Wei Wei
So Samuel K
author_sort Grepper Susan
title Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
title_short Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
title_full Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
title_fullStr Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
title_full_unstemmed Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
title_sort blockade of wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
publisher BMC
series Molecular Cancer
issn 1476-4598
publishDate 2009-09-01
description <p>Abstract</p> <p>Background</p> <p>Hepatocellular carcinoma (HCC) is an aggressive cancer, and is the third leading cause of cancer death worldwide. Standard therapy is ineffective partly because HCC is intrinsically resistant to conventional chemotherapy. Its poor prognosis and limited treatment options make it critical to develop novel and selective chemotherapeutic agents. Since the Wnt/β-catenin pathway is essential in HCC carcinogenesis, we studied the inhibition of Wnt-1-mediated signaling as a potential molecular target in HCC.</p> <p>Results</p> <p>We demonstrated that Wnt-1 is highly expressed in human hepatoma cell lines and a subgroup of human HCC tissues compared to paired adjacent non-tumor tissues. An anti-Wnt-1 antibody dose-dependently decreased viability and proliferation of Huh7 and Hep40 cells over-expressing Wnt-1 and harboring wild type β-catenin, but did not affect normal hepatocytes with undetectable Wnt-1 expression. Apoptosis was also observed in Huh7 and Hep40 cells after treatment with anti-Wnt-1 antibody. In these two cell lines, the anti-Wnt-1 antibody decreased β-catenin/Tcf4 transcriptional activities, which were associated with down-regulation of the endogenous β-catenin/Tcf4 target genes c-Myc, cyclin D1, and survivin. Intratumoral injection of anti-Wnt-1 antibody suppressed <it>in vivo </it>tumor growth in a Huh7 xenograft model, which was also associated with apoptosis and reduced c-Myc, cyclin D1, and survivin expressions.</p> <p>Conclusion</p> <p>Our results suggest that Wnt-1 is a survival factor for HCC cells, and that the blockade of Wnt-1-mediated signaling may offer a potential pathway-specific therapeutic strategy for the treatment of a subgroup of HCC that over-expresses Wnt-1.</p>
url http://www.molecular-cancer.com/content/8/1/76
work_keys_str_mv AT greppersusan blockadeofwnt1signalingleadstoantitumoreffectsinhepatocellularcarcinomacells
AT chuameisze blockadeofwnt1signalingleadstoantitumoreffectsinhepatocellularcarcinomacells
AT weiwei blockadeofwnt1signalingleadstoantitumoreffectsinhepatocellularcarcinomacells
AT sosamuelk blockadeofwnt1signalingleadstoantitumoreffectsinhepatocellularcarcinomacells
_version_ 1725224985056772096